Company & Sponsor Intelligence

Vanderbilt University

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →
Indexed trials11
Recruiting0
Completed10
Countries1

Therapeutic footprint

adhdalzheimersautismdepressionintellectual_disabilitymovement_disordersneurodevelopmental_other

Indexed studies

NCT05178992Use of Socially Assistive Robots for Long Term Care Older Adults With Cognitive Impairment and Apathy
alzheimers · United States
PHASE1, PHASE2
NCT01896934Frontal Hypoperfusion Effects on Antidepressant Outcomes in Late-Life Depression
depression · United States
PHASE4
NCT05223842Family Promoting Positive Emotions Pilot Study
depression · United States
NA
NCT02339935Improving Hospitalizations for Children With ASD
autism · United States
NA
NCT01110343Conventional vs Mindfulness Intervention in Parents of Children With Disabilities
depression · United States
NA
NCT02712996Treatment of Traumatic Brain Injury (TBI)-Related Attention Deficits in Children
adhd · United States
PHASE4
NCT05099705Testing a Family Service Navigator Program for Low-resourced Families of Young Children With Autism Spectrum Disorder
autism · United States
NA
NCT02158390Phenotypic Specific Communication Intervention for Children With Down Syndrome
neurodevelopmental_other · United States
NA
NCT00282191Prevalence of Spasticity in Adults With Mental Retardation Living in the Community
intellectual_disability · United States
COMPLETED
NCT03274622Efficacy of IMPACT in Infant Siblings of Children With ASD
autism · United States
NA
NCT02678429Atlas Predicted DBS Settings in Essential Tremor
movement_disorders · United States
NA

Intelligence layer updated: 2026-10-14 06:11:28.884102+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →